drugset / Trial / NCT00969644

The Relationship Between the Growth Hormone (GH)- Insulin Like Growth Factor I (IGF-I) System and the Inflammatory System in Healthy Normal Persons

NCT00969644

Unknown 12 enrolled Herlev Hospital
RandomizedCrossoverOpen-labelBasic science

Summary

Observations in patients with growth hormone (GH)-disturbances have suggested that GH/IGF-I might have anti-inflammatory effects. To elucidate this hypothesis the investigators have planned a study to investigate if 3 weeks administration of GH and subsequently the GH antagonist Pegvisomant (or vice versa) influence serum levels of different inflammatory markers in healthy volunteers.

Timeline

Start
2009-09
Primary completion
2010-03
Completion
2010-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Pegvisomant Protein / enzyme biologic 15 mg Subcutaneous
Comparator Somatropin Protein / enzyme biologic 30 ug/kg Subcutaneous